EUGENE MELNYK REACHES SETTLEMENT WITH OSC IN PROBE OF BIOVAIL DRUGMAKER
May 6, 2011
Eugene Melnyk reached a settlement with the Ontario Securities Commission in a probe of drugmaker Biovail Corp. As part of the settlement presented to an OSC panel in Toronto today, Melnyk agreed to pay C$565,000 in costs and drop his appeal. Melnyk also faces a five-year ban as a director or officer.
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from Settlement News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
